المؤلفون: van Weelderen RE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Emma Children's Hospital, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Harrison CJ; Leukemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle-upon-Tyne, United Kingdom., Klein K; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Emma Children's Hospital, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Department of Pediatrics, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands., Jiang Y; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Abrahamsson J; Department of Pediatrics, Institute of Clinical Sciences, Salgrenska University Hospital, Gothenburg, Sweden., Alonzo T; Division of Biostatistics, University of Southern California, Los Angeles, CA., Aplenc R; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA., Arad-Cohen N; Department of Pediatric Hematology-Oncology, Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Haifa, Israel., Bart-Delabesse E; Institut Universitaire du Cancer Toulouse-Oncopole, Laboratoire d'Hématologie secteur Génétique des Hémopathies, Toulouse, France., Buldini B; Division of Pediatric Hematology, Oncology, and Stem Cell Transplant, Department of Maternal and Child Health, Padua University, Padua, Italy., De Moerloose B; Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium., Dworzak MN; Department of Pediatrics, St. Anna Children's Hospital, Medical University of Vienna & St. Anna Children's Cancer Research Institute, Vienna, Austria., Elitzur S; Department of Pediatric Hematology and Oncology, Schneider Children's Medical Center & Tel Aviv University, Tel Aviv, Israel., Fernández Navarro JM; Department of Pediatric Oncohematology, Hospital Universitari i Politècnic la Fe, Valencia, Spain., Gamis A; Department of Hematology and Oncology, Children's Mercy Hospital, Kansas City, MO., Gerbing RB; Department of Statistics, Children's Oncology Group, Monrovia, CA., Goemans BF; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., de Groot-Kruseman HA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; DCOG, Dutch Childhood Oncology Group, Utrecht, The Netherlands., Guest E; Department of Hematology and Oncology, Children's Mercy Hospital, Kansas City, MO., Ha SY; Department of Pediatrics & Adolescent Medicine, Hong Kong Children's Hospital, Kowloon Bay, Hong Kong., Hasle H; Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark., Kelaidi C; Department of Pediatric Hematology and Oncology, Aghia Sophia Children's Hospital, Athens, Greece., Lapillonne H; Department of Pediatric Hematology and Oncology, Hôpital Armand Trousseau, Paris, France., Leverger G; Department of Pediatric Hematology and Oncology, Hôpital Armand Trousseau, Paris, France., Locatelli F; Department of Pediatric Hematology and Oncology and Cell and Gene Therapy, IRCCS Ospedale Pediatrico Bambino Gesù, Catholic University of the Sacred Heart, Rome, Italy., Miyamura T; Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan., Norén-Nyström U; Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden., Polychronopoulou S; Department of Pediatric Hematology and Oncology, Aghia Sophia Children's Hospital, Athens, Greece., Rasche M; Department of Pediatric Hematology and Oncology, University Hospital Essen, Essen, Germany., Rubnitz JE; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN., Stary J; Department of Pediatric Hematology and Oncology, University Hospital Motol and Second Faculty of Medicine, Charles University, Prague, Czech Republic., Tierens A; Department of Pathobiology and Laboratory Medicine, University Health Network, Toronto General Hospital, Toronto, ON, Canada., Tomizawa D; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan., Zwaan CM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology, Erasmus Medical Center Sophia Children's Hospital, Rotterdam, The Netherlands., Kaspers GJL; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Emma Children's Hospital, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

المصدر: Blood advances [Blood Adv] 2024 Jun 25; Vol. 8 (12), pp. 3200-3213.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Myeloid-Lymphoid Leukemia Protein*/genetics , Histone-Lysine N-Methyltransferase*/genetics , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/mortality, Humans ; Child ; Male ; Female ; Child, Preschool ; Adolescent ; Infant ; Prognosis ; Chromosome Aberrations ; Gene Rearrangement ; Retrospective Studies

المؤلفون: Poynton E; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.; Department of Clinical Haematology, University College London Hospital, London, United Kingdom., Chernucha E; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom., Day J; Department of Clinical Haematology, University College London Hospital, London, United Kingdom., Prodger C; Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Centre, Oxford, United Kingdom., Hopkins D; Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Rakesh P; Centre for Clinical Haematology, University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom., O'Neill T; Department of Haemato-Oncology, St. Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom., Thakrar N; Department of Clinical Haematology, University College London Hospital, London, United Kingdom., Akarca A; Department of Histopathology, University College London Hospital, London, United Kingdom., Jamal E; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Ali A; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom., Kirkwood AA; Cancer Research UK and UCL Cancer Trial Centre, UCL Cancer Institute, University College London, London, United Kingdom., Pomplun S; Department of Histopathology, University College London Hospital, London, United Kingdom., Marafioti T; Department of Histopathology, University College London Hospital, London, United Kingdom., Calaminici M; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Greaves P; Department of Haematology, Barking Havering and Redbridge University Hospital NHS Trust, Romford, United Kingdom., Chaganti S; Centre for Clinical Haematology, University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom., McKay P; Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Smith J; Clatterbridge Cancer Centre, Liverpool University Hospitals, Liverpool, United Kingdom., Eyre TA; Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Centre, Oxford, United Kingdom., Martinez-Calle N; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom., Cwynarski K; Department of Clinical Haematology, University College London Hospital, London, United Kingdom., Fox CP; School of Medicine, University of Nottingham, Nottingham, United Kingdom., Okosun J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.

المصدر: Blood advances [Blood Adv] 2024 Apr 09; Vol. 8 (7), pp. 1772-1775.

نوع المنشور: Multicenter Study; Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Large B-Cell, Diffuse*/genetics, Humans ; Gene Rearrangement ; Proto-Oncogene Proteins c-bcl-2/genetics ; Proto-Oncogene Proteins c-bcl-2/metabolism ; United Kingdom

المؤلفون: Stewart JP; Patrick G Johnston Centre for Cancer Research, Queens University Belfast, Belfast, United Kingdom., Gazdova J; Patrick G Johnston Centre for Cancer Research, Queens University Belfast, Belfast, United Kingdom., Darzentas N; Department of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany., Wren D; Clinical Genomics, Royal Marsden Hospital, London, United Kingdom., Proszek P; Clinical Genomics, Royal Marsden Hospital, London, United Kingdom., Fazio G; Centro Ricerca Tettamanti, Fondazione MBBM/San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy., Songia S; Centro Ricerca Tettamanti, Fondazione MBBM/San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy., Alcoceba M; University Hospital of Salamanca, Salamanca, Spain.; Centre for Cancer Research (CIC/USAL), Salamanca, Spain., Sarasquete ME; University Hospital of Salamanca, Salamanca, Spain.; Centre for Cancer Research (CIC/USAL), Salamanca, Spain., Villarese P; Laboratory of Onco-Hematology, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, University de Paris, Paris, France., van der Klift MY; Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands., Heezen KC; Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands., McCafferty N; Patrick G Johnston Centre for Cancer Research, Queens University Belfast, Belfast, United Kingdom., Pal K; Department of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany., Catherwood M; Belfast City Hospital, Belfast, United Kingdom., Kim CS; Patrick G Johnston Centre for Cancer Research, Queens University Belfast, Belfast, United Kingdom., Srivastava S; Patrick G Johnston Centre for Cancer Research, Queens University Belfast, Belfast, United Kingdom., Kroeze LI; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Hodges E; Patrick G Johnston Centre for Cancer Research, Queens University Belfast, Belfast, United Kingdom., Stamatopoulos K; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece., Klapper W; Department of Pathology, University of Kiel, Kiel, Germany., Genuardi E; Hematology Division, Department of Molecular Biotechnologies and Health Sciences, University of Turin, Turin, Italy., Ferrero S; Hematology Division, Department of Molecular Biotechnologies and Health Sciences, University of Turin, Turin, Italy., van den Brand M; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Cazzaniga G; Centro Ricerca Tettamanti, Fondazione MBBM/San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy., Davi F; Laboratory of Hematology, Hospital Pitie-Salpetriere, Paris, France; and., Sutton LA; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Garcia-Sanz R; University Hospital of Salamanca, Salamanca, Spain.; Centre for Cancer Research (CIC/USAL), Salamanca, Spain., Groenen PJTA; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Macintyre EA; Laboratory of Onco-Hematology, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, University de Paris, Paris, France., Brüggemann M; Department of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany., Pott C; Department of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany., Langerak AW; Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands., Gonzalez D; Patrick G Johnston Centre for Cancer Research, Queens University Belfast, Belfast, United Kingdom.

مؤلفون مشاركون: EuroClonality-NGS Working Group

المصدر: Blood advances [Blood Adv] 2021 Aug 24; Vol. 5 (16), pp. 3188-3198.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Gene Rearrangement* , Lymphoproliferative Disorders*/diagnosis , Lymphoproliferative Disorders*/genetics, DNA ; Genomics ; Humans ; Immunoglobulins

المؤلفون: Kingsley MC; Division of Pediatric Hematology/Oncology/Bone Marrow Transplant, University of Colorado School of Medicine-Children's Hospital Colorado Aurora, CO.; Division of Pediatric Oncology, Department of Pediatrics, Center for Childhood Cancer Research and., Xie HM; Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA., Chen BR; Tumor Initiation and Maintenance Program, Sanford Burnham Medical Discovery Institute, La Jolla, CA., Riedel SS; Division of Pediatric Oncology, Department of Pediatrics, Center for Childhood Cancer Research and., Pastuer T; Division of Pediatric Hematology/Oncology/Bone Marrow Transplant, University of Colorado School of Medicine-Children's Hospital Colorado Aurora, CO., Bollig MK; Division of Pediatric Hematology/Oncology/Bone Marrow Transplant, University of Colorado School of Medicine-Children's Hospital Colorado Aurora, CO., Shank T; Division of Pediatric Hematology/Oncology/Bone Marrow Transplant, University of Colorado School of Medicine-Children's Hospital Colorado Aurora, CO., Libbrecht C; Division of Pediatric Oncology, Department of Pediatrics, Center for Childhood Cancer Research and., Stabler SP; Division of Hematology, University of Colorado-Denver, Aurora, CO., Deshpande AJ; Tumor Initiation and Maintenance Program, Sanford Burnham Medical Discovery Institute, La Jolla, CA., Intlekofer AM; Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; and., Bernt KM; Division of Pediatric Oncology, Department of Pediatrics, Center for Childhood Cancer Research and.; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania-Abramson Cancer Center, Philadelphia, PA.

المصدر: Blood advances [Blood Adv] 2020 Jul 14; Vol. 4 (13), pp. 3109-3122.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Gene Rearrangement* , Leukemia, Myeloid, Acute*/genetics, Histones/metabolism ; Humans ; Methylation ; Oncogenes

المؤلفون: Al-Kershi S; Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany., Bhayadia R; Pediatric Hematology and Oncology, Martin Luther University Halle-Wittenberg, Halle, Germany., Ng M; Pediatric Hematology and Oncology, Martin Luther University Halle-Wittenberg, Halle, Germany., Verboon L; Pediatric Hematology and Oncology, Martin Luther University Halle-Wittenberg, Halle, Germany., Emmrich S; Department of Biology, University of Rochester, Rochester, NY., Gack L; Pediatric Hematology and Oncology, Martin Luther University Halle-Wittenberg, Halle, Germany., Schwarzer A; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany; and., Strowig T; Helmholtz Centre for Infection Research, Braunschweig, Germany., Heckl D; Pediatric Hematology and Oncology, Martin Luther University Halle-Wittenberg, Halle, Germany., Klusmann JH; Pediatric Hematology and Oncology, Martin Luther University Halle-Wittenberg, Halle, Germany.

المصدر: Blood advances [Blood Adv] 2019 Dec 23; Vol. 3 (24), pp. 4252-4263.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Gene Rearrangement* , RNA, Antisense* , RNA, Long Noncoding*, Histone-Lysine N-Methyltransferase/*genetics , Homeobox A10 Proteins/*genetics , Leukemia/*genetics , Myeloid-Lymphoid Leukemia Protein/*genetics , Neoplastic Stem Cells/*metabolism, Animals ; Disease Models, Animal ; Flow Cytometry ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Humans ; Leukemia/diagnosis ; Leukemia/mortality ; Leukemia/therapy ; Leukemia, Myeloid, Acute/genetics ; Leukemia, Myeloid, Acute/metabolism ; Leukemia, Myeloid, Acute/pathology ; Mice ; NF-kappa B/metabolism ; Neoplastic Stem Cells/pathology ; Nucleophosmin ; Prognosis ; Transcriptome

المؤلفون: Eertink JJ; Department of Hematology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands., Zwezerijnen GJC; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Wiegers SE; Department of Hematology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands., Pieplenbosch S; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Chamuleau MED; Department of Hematology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands., Lugtenburg PJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., de Jong D; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Ylstra B; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Mendeville M; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Dührsen U; Department of Hematology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Hanoun C; Department of Hematology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Hüttmann A; Department of Hematology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Richter J; Hematopathology Section, Department of Pathology, University Hospital Schleswig-Holstein, Christian-Albrecht-University of Kiel, Kiel, Germany., Klapper W; Hematopathology Section, Department of Pathology, University Hospital Schleswig-Holstein, Christian-Albrecht-University of Kiel, Kiel, Germany., Jauw YWS; Department of Hematology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Hoekstra OS; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., de Vet HCW; Department of Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Department of Methodology, Amsterdam Public Health, Amsterdam, The Netherlands., Boellaard R; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Zijlstra JM; Department of Hematology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.

المصدر: Blood advances [Blood Adv] 2023 Jan 24; Vol. 7 (2), pp. 214-223.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Large B-Cell, Diffuse*/diagnostic imaging , Lymphoma, Large B-Cell, Diffuse*/genetics , Proto-Oncogene Proteins c-myc*/genetics, Humans ; Gene Rearrangement ; In Situ Hybridization, Fluorescence ; Positron Emission Tomography Computed Tomography ; Prognosis

المؤلفون: Wölfl M; Pediatric Hematology, Oncology and Stem Cell Transplantation, Children's Hospital, University of Würzburg, Würzburg, Germany; and., Rasche M; Department of Pediatric Hematology/Oncology, Pediatrics III, University Hospital of Essen, Essen, Germany., Eyrich M; Pediatric Hematology, Oncology and Stem Cell Transplantation, Children's Hospital, University of Würzburg, Würzburg, Germany; and., Schmid R; Pediatric Hematology, Oncology and Stem Cell Transplantation, Children's Hospital, University of Würzburg, Würzburg, Germany; and., Reinhardt D; Department of Pediatric Hematology/Oncology, Pediatrics III, University Hospital of Essen, Essen, Germany., Schlegel PG; Pediatric Hematology, Oncology and Stem Cell Transplantation, Children's Hospital, University of Würzburg, Würzburg, Germany; and.

المصدر: Blood advances [Blood Adv] 2018 Jun 26; Vol. 2 (12), pp. 1382-1385.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Gene Rearrangement*, Antibodies, Bispecific/*pharmacology , Histone-Lysine N-Methyltransferase/*genetics , Leukemia, Myeloid, Acute/*chemically induced , Myeloid-Lymphoid Leukemia Protein/*genetics , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/*pathology, Antibodies, Bispecific/therapeutic use ; Blast Crisis/drug therapy ; Blast Crisis/pathology ; Female ; Humans ; Immunotherapy ; Infant

المؤلفون: Frauenfeld L; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany., Castrejon-de-Anta N; Hematopathology Unit, Hospital Clínic de Barcelona, Barcelona, Spain., Ramis-Zaldivar JE; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Streich S; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany., Salmerón-Villalobos J; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Otto F; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany., Mayer AK; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany., Steinhilber J; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany., Pinyol M; Hematopathology Unit, Hospital Clínic de Barcelona, Barcelona, Spain., Mankel B; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany., Ramsower C; Department of Research, and.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ; and., Bonzheim I; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany., Fend F; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany., Rimsza LM; Department of Research, and.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ; and., Salaverria I; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Campo E; Hematopathology Unit, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Balagué O; Hematopathology Unit, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Quintanilla-Martinez L; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180), University of Tübingen, Tübingen, Germany.

المصدر: Blood advances [Blood Adv] 2022 Apr 12; Vol. 6 (7), pp. 2361-2372.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Large B-Cell, Diffuse*/pathology , Myeloid Differentiation Factor 88*/genetics, Adult ; Antigens, CD ; Child ; Gene Rearrangement ; Humans ; In Situ Hybridization, Fluorescence ; Interferon Regulatory Factors ; Proto-Oncogene Proteins c-bcl-2/genetics ; Proto-Oncogene Proteins c-bcl-6/genetics ; Semaphorins ; Translocation, Genetic

المؤلفون: Tran TH; Department of Pediatrics, Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine, Montréal, QC, Canada.; Immune Diseases and Cancers Axis, CHU Sainte-Justine Research Center, Montréal, QC, Canada., Langlois S; Immune Diseases and Cancers Axis, CHU Sainte-Justine Research Center, Montréal, QC, Canada., Meloche C; Immune Diseases and Cancers Axis, CHU Sainte-Justine Research Center, Montréal, QC, Canada., Caron M; Immune Diseases and Cancers Axis, CHU Sainte-Justine Research Center, Montréal, QC, Canada., Saint-Onge P; Immune Diseases and Cancers Axis, CHU Sainte-Justine Research Center, Montréal, QC, Canada., Rouette A; Department of Pediatrics, Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine, Montréal, QC, Canada., Bataille AR; Immune Diseases and Cancers Axis, CHU Sainte-Justine Research Center, Montréal, QC, Canada., Jimenez-Cortes C; Immune Diseases and Cancers Axis, CHU Sainte-Justine Research Center, Montréal, QC, Canada., Sontag T; Immune Diseases and Cancers Axis, CHU Sainte-Justine Research Center, Montréal, QC, Canada., Bittencourt H; Department of Pediatrics, Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine, Montréal, QC, Canada.; Immune Diseases and Cancers Axis, CHU Sainte-Justine Research Center, Montréal, QC, Canada., Laverdière C; Department of Pediatrics, Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine, Montréal, QC, Canada.; Immune Diseases and Cancers Axis, CHU Sainte-Justine Research Center, Montréal, QC, Canada., Lavallée VP; Department of Pediatrics, Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine, Montréal, QC, Canada.; Immune Diseases and Cancers Axis, CHU Sainte-Justine Research Center, Montréal, QC, Canada., Leclerc JM; Department of Pediatrics, Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine, Montréal, QC, Canada.; Immune Diseases and Cancers Axis, CHU Sainte-Justine Research Center, Montréal, QC, Canada., Cole PD; Division of Pediatric Hematology/Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Gennarini LM; Division of Pediatric Hematology-Oncology, Montefiore Medical Center, Bronx, NY., Kahn JM; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Irving Medical Center, New York, NY., Kelly KM; Department of Pediatrics, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Michon B; Division of Pediatric Hematology-Oncology, CHU de Quebec, Saint-Foy, QC, Canada., Santiago R; Division of Pediatric Hematology-Oncology, CHU de Quebec, Saint-Foy, QC, Canada., Stevenson KE; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Welch JJG; Division of Pediatric Hematology Oncology, Hasbro Children's Hospital/Brown University, Providence, RI; and., Schroeder KM; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA., Koch V; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA., Cellot S; Department of Pediatrics, Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine, Montréal, QC, Canada.; Immune Diseases and Cancers Axis, CHU Sainte-Justine Research Center, Montréal, QC, Canada., Silverman LB; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA., Sinnett D; Department of Pediatrics, Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine, Montréal, QC, Canada.; Immune Diseases and Cancers Axis, CHU Sainte-Justine Research Center, Montréal, QC, Canada.

المصدر: Blood advances [Blood Adv] 2022 Feb 22; Vol. 6 (4), pp. 1329-1341.

نوع المنشور: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Philadelphia Chromosome* , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics, Child ; Gene Expression Profiling ; Gene Rearrangement ; Humans ; Multicenter Studies as Topic ; Prospective Studies

المؤلفون: Shah YB; Comprehensive Bone Marrow Failure Center, Children's Hospital of Philadelphia, Philadelphia, PA., Priore SF; Division of Precision and Computational Diagnostics, Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA., Li Y; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Tang CN; Division of Precision and Computational Diagnostics, Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA., Nicholas P; Comprehensive Bone Marrow Failure Center, Children's Hospital of Philadelphia, Philadelphia, PA., Kurre P; Comprehensive Bone Marrow Failure Center, Children's Hospital of Philadelphia, Philadelphia, PA., Olson TS; Comprehensive Bone Marrow Failure Center, Children's Hospital of Philadelphia, Philadelphia, PA.; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA; and., Babushok DV; Comprehensive Bone Marrow Failure Center, Children's Hospital of Philadelphia, Philadelphia, PA.; Division of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.

المصدر: Blood advances [Blood Adv] 2021 Aug 24; Vol. 5 (16), pp. 3216-3226.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Anemia, Aplastic*/diagnosis , Anemia, Aplastic*/genetics , Hemoglobinuria, Paroxysmal*/diagnosis , Hemoglobinuria, Paroxysmal*/genetics, Bayes Theorem ; Child ; Clone Cells ; Gene Rearrangement ; Humans